Research News
2012
- Dr. Bryan McNally and Dr. Arthur Kellermann: Association of Neighborhood Characteristics with Bystander-Initiated CPR. Future training in bystander CPR needs targeted approach in "high-risk" neighborhoods, according to study. This story has been picked up by more than 100 media outliets, including NPR, Reuters. and Atlanta Journal-Constitution
- Dr. Don Stein: Game Changer: Transforming the science and practice of medicine
- The Palliative Care Center received a $250,000 grant from the HealthCare Chaplaincy-Templeton Foundation to study the impact of hospital-based chaplain support on decision-making during serious illness. This was one of six grants funded out of 72 applications from the U.S. and Canada. Palliative care physician Dr. Tammie Quest will be principal investigator on this grant, which also involves pastoral care, the nursing school, geriatrics, and the department of sociology in Emory College. Based at Emory University Hospital Midtown, the project seeks enhanced understanding of the role of the chaplain in spiritual-based end-of-life decision-making in African Americans.
- Study tests if progesterone can save lives after brain injury. "Although we think of it as a female hormone, there are a lot of clues in nature that this compound has multiple roles in the human body," said Dr. David Wright, an associate professor of emergency medicine at Emory who collaborates with Dr. Donald Stein, a neuroscientist and a professor of emergency medicine at Emory and is lead investigator of the current clinical trial.
- EM participates in groundbreaking study for treatment of patients with prolonged epileptic seizures
- Emory initiated CARES program has helped to double cardiac-arrest-survival rate. CARES, first deployed in Atlanta, now serves over 65 million Americans in over 40 communities, across in over 28 states.
- Blood biomarker studies, using the large patient group from the ProTECT III trial, focus on stroke and TBI
- Emory School of Medicine Joins Forces with First Lady Michelle Obama to Combat PTSD and Traumatic Brain injury
2011
- NIH-Funded Researchers Assess Traumatic Brain Injury Biomarkers
- Progesterone Inhibis Growth of Neuroblastoma Cancer Cells
- Banyan Biomarkers, Inc. Works with Emory University to Analyze Biomarkers in the Clinical Trial of Progesterone in Traumatic Brain Injury
- Emory Research Offers Hope to Brain Injury Victims
- DoD, NIH Partner to Create TBI Research Database
2010
- Atlanta To Serve as National Epicenter for Promising Phase III Brain Injury Treatment Trial
- Progesterone for Traumatic Brain Injury Tested
- Progesterone for Traumatic Brain Injury Tested in Phase III Clinical Trial
- Progesterone May Help Treat Traumatic Brain Injury Patients, Phase III Trial To Start
Older News
-
- Emory Announces Phase III Study of Progesterone for Traumatic Brain Injury. NIH Grant Will Allow Nationwide Network to Study Effects of Hormone's Effectiveness
- Study Findings Assist EMS with Cardiac Arrest Emergencies
- Portable Device Quickly Detects Alzheimers
- New Technology Could Detect Concussions within Minutes
- One Doctor's Lonely Quest to Heal Brain Injury